Paul Stroobant
22Patents
7h-index
8Co-inventors
58Inventor score
Filing activity: Mar 24, 1993 → Dec 27, 2007
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5530109A | DNA encoding glial mitogenic factors | Chemistry; Metallurgy | 66 | Expired |
| US5716930A | Glial growth factors | Chemistry; Metallurgy | 48 | Expired |
| US5594114A | Schwann cell mitogenic factor, its preparation and use | Human Necessities | 34 | Expired |
| US6232286A | Methods of stimulating mitogenesis in glial cells using glial mitogenic factors | Chemistry; Metallurgy | 19 | Expired |
| US5602096A | Method of using a secretable glial mitogenic factor to induce acetylcholine receptor synthesis | Chemistry; Metallurgy | 9 | Expired |
| US7319019B1 | Glial mitogenic factors lacking an N-terminal signal sequence | Chemistry; Metallurgy | 7 | Expired |
| US6147190A | Glial mitogenic factors, their preparation and use | Chemistry; Metallurgy | 7 | Expired |
| US5854220A | Glial mitogenic factors, their preparation and use | Chemistry; Metallurgy | 6 | Expired |
| US7135456B1 | Glial mitogenic factors, their preparation and use | Human Necessities | 4 | Expired |
| US6972280B2 | Glial mitogenic factors, their preparation and use | Human Necessities | 3 | Expired |
| US7094749B1 | Glial mitogenic factors, their preparation and use | Human Necessities | 2 | Expired |
| US7285531B1 | Method for prophylaxis or treatment of a nervous system, pathophysiological condition involving a glial growth factor sensitive cell by administration of a glial growth factor | Human Necessities | 2 | Expired |
| US7208268B2 | Differential phage capture proteomics | Physics | 1 | Expired |
| US7968678B2 | Glial mitogenic factors, their preparation and use | Chemistry; Metallurgy | 1 | Active |
| US5606032A | Process for preparing glial mitogenic factors | Chemistry; Metallurgy | 1 | Expired |
| US5621081A | Glial mitogenic factors | Chemistry; Metallurgy | 1 | Expired |
| US7977279B2 | Differential phage capture proteomics | Physics | 0 | Active |
| US5792849A | Glial mitogenic factors, their preparation and use | Chemistry; Metallurgy | 0 | Expired |
| US7541338B2 | Glial mitogenic factors, their preparation and use | Human Necessities | 0 | Active |
| US7192915B1 | Methods for treating multiple sclerosis with GGF-related polypeptides | Human Necessities | 0 | Expired |
| US6194377A | Methods for treating nervous system pathophysiologies using glial growth factors | Human Necessities | 0 | Expired |
| US6204241A | Method for treating nervous system pathophysiologies using glial growth factors | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.